355 related articles for article (PubMed ID: 28179577)
21. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
22. Head-to-Head Comparison and Evaluation of 92 Plasma Protein Biomarkers for Early Detection of Colorectal Cancer in a True Screening Setting.
Chen H; Zucknick M; Werner S; Knebel P; Brenner H
Clin Cancer Res; 2015 Jul; 21(14):3318-26. PubMed ID: 26015516
[TBL] [Abstract][Full Text] [Related]
23. Fecal Fatty Acid Profiling as a Potential New Screening Biomarker in Patients with Colorectal Cancer.
Song EM; Byeon JS; Lee SM; Yoo HJ; Kim SJ; Lee SH; Chang K; Hwang SW; Yang DH; Jeong JY
Dig Dis Sci; 2018 May; 63(5):1229-1236. PubMed ID: 29516324
[TBL] [Abstract][Full Text] [Related]
24. Potential metabolomic biomarkers for reliable diagnosis of Behcet's disease using gas chromatography/ time-of-flight-mass spectrometry.
Ahn JK; Kim J; Hwang J; Song J; Kim KH; Cha HS
Joint Bone Spine; 2018 May; 85(3):337-343. PubMed ID: 28549946
[TBL] [Abstract][Full Text] [Related]
25. Breast cancer detection using targeted plasma metabolomics.
Jasbi P; Wang D; Cheng SL; Fei Q; Cui JY; Liu L; Wei Y; Raftery D; Gu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():26-37. PubMed ID: 30562627
[TBL] [Abstract][Full Text] [Related]
26. Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer.
Ikeda A; Nishiumi S; Shinohara M; Yoshie T; Hatano N; Okuno T; Bamba T; Fukusaki E; Takenawa T; Azuma T; Yoshida M
Biomed Chromatogr; 2012 May; 26(5):548-58. PubMed ID: 21773981
[TBL] [Abstract][Full Text] [Related]
27. Targeted serum metabolite profiling and sequential metabolite ratio analysis for colorectal cancer progression monitoring.
Zhu J; Djukovic D; Deng L; Gu H; Himmati F; Abu Zaid M; Chiorean EG; Raftery D
Anal Bioanal Chem; 2015 Oct; 407(26):7857-63. PubMed ID: 26342311
[TBL] [Abstract][Full Text] [Related]
28. An integrated proteomics and metabolomics approach for defining oncofetal biomarkers in the colorectal cancer.
Ma Y; Zhang P; Wang F; Liu W; Yang J; Qin H
Ann Surg; 2012 Apr; 255(4):720-30. PubMed ID: 22395091
[TBL] [Abstract][Full Text] [Related]
29. A novel gas chromatography mass spectrometry-based serum diagnostic and assessment approach to ulcerative colitis.
Kohashi M; Nishiumi S; Ooi M; Yoshie T; Matsubara A; Suzuki M; Hoshi N; Kamikozuru K; Yokoyama Y; Fukunaga K; Nakamura S; Azuma T; Yoshida M
J Crohns Colitis; 2014 Sep; 8(9):1010-21. PubMed ID: 24582087
[TBL] [Abstract][Full Text] [Related]
30. Multiplex quantitation of 270 plasma protein markers to identify a signature for early detection of colorectal cancer.
Bhardwaj M; Weigl K; Tikk K; Holland-Letz T; Schrotz-King P; Borchers CH; Brenner H
Eur J Cancer; 2020 Mar; 127():30-40. PubMed ID: 31972396
[TBL] [Abstract][Full Text] [Related]
31. Metabolomics in diagnosis and biomarker discovery of colorectal cancer.
Zhang A; Sun H; Yan G; Wang P; Han Y; Wang X
Cancer Lett; 2014 Apr; 345(1):17-20. PubMed ID: 24333717
[TBL] [Abstract][Full Text] [Related]
32. Fecal Metabolome in Hmga1 Transgenic Mice with Polyposis: Evidence for Potential Screen for Early Detection of Precursor Lesions in Colorectal Cancer.
Williams MD; Xian L; Huso T; Park JJ; Huso D; Cope LM; Gang DR; Siems WF; Resar L; Reeves R; Hill HH
J Proteome Res; 2016 Dec; 15(12):4176-4187. PubMed ID: 27696867
[TBL] [Abstract][Full Text] [Related]
33. Tissue Metabonomic Phenotyping for Diagnosis and Prognosis of Human Colorectal Cancer.
Tian Y; Xu T; Huang J; Zhang L; Xu S; Xiong B; Wang Y; Tang H
Sci Rep; 2016 Feb; 6():20790. PubMed ID: 26876567
[TBL] [Abstract][Full Text] [Related]
34. Lipid profiling for early diagnosis and progression of colorectal cancer using direct-infusion electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry.
Li F; Qin X; Chen H; Qiu L; Guo Y; Liu H; Chen G; Song G; Wang X; Li F; Guo S; Wang B; Li Z
Rapid Commun Mass Spectrom; 2013 Jan; 27(1):24-34. PubMed ID: 23239314
[TBL] [Abstract][Full Text] [Related]
35. Serum fatty acid profiling of colorectal cancer by gas chromatography/mass spectrometry.
Kondo Y; Nishiumi S; Shinohara M; Hatano N; Ikeda A; Yoshie T; Kobayashi T; Shiomi Y; Irino Y; Takenawa T; Azuma T; Yoshida M
Biomark Med; 2011 Aug; 5(4):451-60. PubMed ID: 21861667
[TBL] [Abstract][Full Text] [Related]
36. Altered plasma levels of decanoic acid in colorectal cancer as a new diagnostic biomarker.
Crotti S; Agnoletto E; Cancemi G; Di Marco V; Traldi P; Pucciarelli S; Nitti D; Agostini M
Anal Bioanal Chem; 2016 Sep; 408(23):6321-8. PubMed ID: 27379390
[TBL] [Abstract][Full Text] [Related]
37. Human plasma metabolomics for identifying differential metabolites and predicting molecular subtypes of breast cancer.
Fan Y; Zhou X; Xia TS; Chen Z; Li J; Liu Q; Alolga RN; Chen Y; Lai MD; Li P; Zhu W; Qi LW
Oncotarget; 2016 Mar; 7(9):9925-38. PubMed ID: 26848530
[TBL] [Abstract][Full Text] [Related]
38. Metabolomic prediction of endometrial cancer.
Bahado-Singh RO; Lugade A; Field J; Al-Wahab Z; Han B; Mandal R; Bjorndahl TC; Turkoglu O; Graham SF; Wishart D; Odunsi K
Metabolomics; 2017 Dec; 14(1):6. PubMed ID: 30830361
[TBL] [Abstract][Full Text] [Related]
39. Highly sensitive and selective analysis of widely targeted metabolomics using gas chromatography/triple-quadrupole mass spectrometry.
Tsugawa H; Tsujimoto Y; Sugitate K; Sakui N; Nishiumi S; Bamba T; Fukusaki E
J Biosci Bioeng; 2014 Jan; 117(1):122-8. PubMed ID: 23867096
[TBL] [Abstract][Full Text] [Related]
40. A prospective study of serum metabolites and colorectal cancer risk.
Cross AJ; Moore SC; Boca S; Huang WY; Xiong X; Stolzenberg-Solomon R; Sinha R; Sampson JN
Cancer; 2014 Oct; 120(19):3049-57. PubMed ID: 24894841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]